TCT 2019: BD, VIVA Data Show Lower Paclitaxel Mortality Risk

BD said an independent Lutonix review found no significant link to deaths, while further meta-analysis from trade group VIVA showed a decline in the risk.  Both studies were unveiled at the Transcatheter Cardiovascular Therapeutics (TCT) conference in San Francisco.